Minneapolis, MN, July 13, 2026 – United Theranostics Parent, LLC (“United Theranostics” or the “Company”), a national network of Nuclear Oncology Centers of Excellence™, has announced the appointment of Ashley Brown as Senior Vice President of Nuclear Medicine Operations. In this role, she will lead nuclear medicine and theranostics operations across the Company’s growing national network of outpatient clinics.
“As we continue expanding our clinic footprint and advancing our mission of bringing theranostics to more patients, it’s critical that we build a leadership team with the right depth of clinical expertise. Ashley brings an incredible amount of that experience to the table, having led nuclear medicine and theranostics programs at some of the country’s top academic health systems. She will have a significant impact at United Theranostics as we continue to grow.”
–Rob Cherney, Chief Executive Officer, United Theranostics
She brings nearly 20 years of experience in nuclear medicine, PET/CT, and theranostics leadership across major academic health systems to United Theranostics. Most recently, she led enterprise nuclear medicine and PET operations at Keck Medicine of USC, where she also supported the development of a large-scale integrated theranostics program. Prior to Keck, she held senior leadership roles at Cedars-Sinai Medical Center and Wise Health System, where she built and led nuclear medicine and PET programs in both academic and community settings.
She will have full operational responsibility across United Theranostics’ outpatient network, including clinical workflow design and optimization, regulatory compliance and radiation safety, radiopharmaceutical operations, staffing and workforce development, and the clinical setup and integration of new facilities.
“What drew me to United Theranostics is the clarity of the mission. Having spent years building theranostics programs within large academic health systems, I’ve seen how meaningful access to these therapies can be for patients, and how difficult it still is for many people to find. United Theranostics is solving that problem at scale, and I’m proud to be part of that work.”
–Ashley Brown, Senior Vice President of Nuclear Medicine Operations, United Theranostics
About United Theranostics
United Theranostics is a national leader in providing cutting-edge radiopharmaceutical therapy and advanced molecular imaging in a comfortable, patient-centric outpatient setting. The Company is dedicated to making personalized theranostics cancer treatment, including clinical trials, accessible to all patients.
For more information about United Theranostics, visit unitedtheranostics.com